BioWorld

July 7, 2004

View Archived Issues

Chiron Takes Over Sagres, Gains Wealth' Of Targets

Looking to boost the value of its recent cancer deal with XOMA Ltd., Chiron Corp. is acquiring Sagres Discovery Inc. for undisclosed terms. (BioWorld Today) Read More

FDA Clears NeutroSpec, Gives Palatin First Product Approval

Read More

Despite Pressure, FDA Backing Authorized Generic' Marketing

Read More

Novo Taking More Proteins In Deal With ZymoGenetics

Read More

Other News To Note

Read More

Correction

Read More